WO2005121753A1 - Method of detecting an analyte using a holographic sensor - Google Patents
Method of detecting an analyte using a holographic sensor Download PDFInfo
- Publication number
- WO2005121753A1 WO2005121753A1 PCT/GB2005/002222 GB2005002222W WO2005121753A1 WO 2005121753 A1 WO2005121753 A1 WO 2005121753A1 GB 2005002222 W GB2005002222 W GB 2005002222W WO 2005121753 A1 WO2005121753 A1 WO 2005121753A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- analyte
- medium
- catalyst
- glucose
- holographic
- Prior art date
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 title claims abstract description 31
- 239000003054 catalyst Substances 0.000 claims abstract description 20
- 238000006243 chemical reaction Methods 0.000 claims abstract description 17
- 238000001514 detection method Methods 0.000 claims abstract description 12
- 239000012530 fluid Substances 0.000 claims abstract description 12
- 230000003287 optical effect Effects 0.000 claims abstract description 12
- 230000003993 interaction Effects 0.000 claims abstract description 8
- 230000000704 physical effect Effects 0.000 claims abstract description 7
- 230000008859 change Effects 0.000 claims abstract description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 41
- 239000008103 glucose Substances 0.000 claims description 37
- -1 tile Substances 0.000 claims description 17
- 108700040099 Xylose isomerases Proteins 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 12
- 102000020006 aldose 1-epimerase Human genes 0.000 claims description 10
- 108091022872 aldose 1-epimerase Proteins 0.000 claims description 10
- 238000012360 testing method Methods 0.000 claims description 8
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 7
- 230000005855 radiation Effects 0.000 claims description 7
- 239000007943 implant Substances 0.000 claims description 6
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 5
- 238000009434 installation Methods 0.000 claims description 4
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical group OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 claims description 4
- 238000005070 sampling Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 238000009450 smart packaging Methods 0.000 claims description 3
- 102000016938 Catalase Human genes 0.000 claims description 2
- 108010053835 Catalase Proteins 0.000 claims description 2
- 108010015776 Glucose oxidase Proteins 0.000 claims description 2
- 239000004366 Glucose oxidase Substances 0.000 claims description 2
- 102000003855 L-lactate dehydrogenase Human genes 0.000 claims description 2
- 108700023483 L-lactate dehydrogenases Proteins 0.000 claims description 2
- 230000005540 biological transmission Effects 0.000 claims description 2
- 239000011449 brick Substances 0.000 claims description 2
- 239000000919 ceramic Substances 0.000 claims description 2
- 238000013500 data storage Methods 0.000 claims description 2
- 230000002999 depolarising effect Effects 0.000 claims description 2
- 230000007613 environmental effect Effects 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 229940116332 glucose oxidase Drugs 0.000 claims description 2
- 235000019420 glucose oxidase Nutrition 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 150000002739 metals Chemical class 0.000 claims description 2
- 239000003973 paint Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims description 2
- 239000002023 wood Substances 0.000 claims description 2
- 150000003893 lactate salts Chemical group 0.000 claims 2
- 230000002708 enhancing effect Effects 0.000 claims 1
- 230000005389 magnetism Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 39
- 229960001031 glucose Drugs 0.000 description 39
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 8
- 229920002451 polyvinyl alcohol Polymers 0.000 description 8
- 239000004372 Polyvinyl alcohol Substances 0.000 description 7
- AVVWPBAENSWJCB-UKFBFLRUSA-N alpha-D-glucofuranose Chemical compound OC[C@@H](O)[C@H]1O[C@H](O)[C@H](O)[C@H]1O AVVWPBAENSWJCB-UKFBFLRUSA-N 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 239000000017 hydrogel Substances 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 125000005620 boronic acid group Chemical class 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 3
- WQZGKKKJIJFFOK-UHFFFAOYSA-N alpha-D-glucopyranose Natural products OCC1OC(O)C(O)C(O)C1O WQZGKKKJIJFFOK-UHFFFAOYSA-N 0.000 description 3
- AVVWPBAENSWJCB-QZABAPFNSA-N beta-D-glucofuranose Chemical compound OC[C@@H](O)[C@H]1O[C@@H](O)[C@H](O)[C@H]1O AVVWPBAENSWJCB-QZABAPFNSA-N 0.000 description 3
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 208000010412 Glaucoma Diseases 0.000 description 2
- 229920002396 Polyurea Polymers 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
- 229960002246 beta-d-glucopyranose Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920001281 polyalkylene Polymers 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- KVZLHPXEUGJPAH-UHFFFAOYSA-N 2-oxidanylpropanoic acid Chemical compound CC(O)C(O)=O.CC(O)C(O)=O KVZLHPXEUGJPAH-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102100026735 Coagulation factor VIII Human genes 0.000 description 1
- AVVWPBAENSWJCB-IVMDWMLBSA-N D-glucofuranose Chemical compound OC[C@@H](O)[C@H]1OC(O)[C@H](O)[C@H]1O AVVWPBAENSWJCB-IVMDWMLBSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 241000604136 Pediococcus sp. Species 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000187417 Streptomyces rubiginosus Species 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- ULVXDHIJOKEBMW-UHFFFAOYSA-N [3-(prop-2-enoylamino)phenyl]boronic acid Chemical compound OB(O)C1=CC=CC(NC(=O)C=C)=C1 ULVXDHIJOKEBMW-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 210000001742 aqueous humor Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 210000003717 douglas' pouch Anatomy 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920000083 poly(allylamine) Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229920006301 statistical copolymer Polymers 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4788—Diffraction
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H1/00—Holographic processes or apparatus using light, infrared or ultraviolet waves for obtaining holograms or for obtaining an image from them; Details peculiar thereto
- G03H1/02—Details of features involved during the holographic process; Replication of holograms without interference recording
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H1/00—Holographic processes or apparatus using light, infrared or ultraviolet waves for obtaining holograms or for obtaining an image from them; Details peculiar thereto
- G03H1/0005—Adaptation of holography to specific applications
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H1/00—Holographic processes or apparatus using light, infrared or ultraviolet waves for obtaining holograms or for obtaining an image from them; Details peculiar thereto
- G03H1/0005—Adaptation of holography to specific applications
- G03H1/0011—Adaptation of holography to specific applications for security or authentication
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H1/00—Holographic processes or apparatus using light, infrared or ultraviolet waves for obtaining holograms or for obtaining an image from them; Details peculiar thereto
- G03H1/02—Details of features involved during the holographic process; Replication of holograms without interference recording
- G03H1/024—Hologram nature or properties
- G03H1/0248—Volume holograms
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H1/00—Holographic processes or apparatus using light, infrared or ultraviolet waves for obtaining holograms or for obtaining an image from them; Details peculiar thereto
- G03H1/0005—Adaptation of holography to specific applications
- G03H2001/0033—Adaptation of holography to specific applications in hologrammetry for measuring or analysing
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H2210/00—Object characteristics
- G03H2210/50—Nature of the object
- G03H2210/55—Having particular size, e.g. irresolvable by the eye
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H2270/00—Substrate bearing the hologram
- G03H2270/55—Substrate bearing the hologram being an optical element, e.g. spectacles
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
Definitions
- This invention relates to a method for the detection of an analyte using a holographic sensor.
- a holographic sensor for the detection of an analyte.
- This sensor comprises a holographic element comprising a support medium and a hologram disposed throughout the volume of the medium.
- An optical characteristic of the element changes a result of a variation of a physical property occurring throughout the volume of the medium, the variation arising as a result of reaction between the medium and the analyte. By monitoring any change in the optical characteristic, the presence of the analyte can be detected.
- WO03/087789 describes a process for the continuous sensing of an analyte using a holographic sensor.
- a particular analyte of interest is glucose.
- glucose sensors particularly ophthalmic glucose sensors.
- concentration of glucose in the blood is typically of the order of 20 mM, whereas in the eye it is about 0.1 mM.
- the levels of glucose in the eye are known to correlate to those in the blood.
- blood levels of glucose can be monitored indirectly by measuring the levels in an ocular fluid such as tears.
- Glucose also known as D-glucose
- the four cyclic forms of glucose namely ⁇ -D-glucopyranose, ⁇ -D-glucopyranose, ⁇ -D- glucofuranose and ⁇ -D-glucofuranose, coexist in equilibrium with the acyclic form, D-glucose aldehyde, via a process called "complex mutarotation".
- the proportions of the ⁇ -D-glucopyranose, ⁇ -D-glucopyranose, ⁇ -D-' glucofuranose, ⁇ -D-glucofuranose and D-glucose aldehyde are about 39.4, 60.2, 0.2, 0.2 and 0.001 % respectively (Shoji et al, J. Am.
- the enzyme mutarotase catalyses the conversion of the ⁇ -forms ⁇ via the linear form) to ⁇ -D- glucofuranose.
- the extent of reaction can be increased by first converting glucose to fructose or ribose, using an enzyme such as glucose isomerase.
- Fructose and ribose react with boronic acids in an analogous manner to glucose.
- Summary of the Invention The present invention is based upon the realisation that the response of a holographic sensor can be increased by detecting any interaction between the holographic support medium and analyte in the presence of an agent, more specifically a catalyst, which enhances that interaction.
- a holographic sensor comprising pendant boronic acid groups may be used for the detection of glucose.
- the levels of the ⁇ -D-glucofuranose form are generally very low, the time and level of response of such a sensor may be poor.
- the response may be dramatically enhanced by carrying out detection in the presence an enzyme such as mutarotase or glucose isomerase.
- a first aspect of the invention is a method for the detection of an analyte in a fluid, which comprises contacting the fluid with a holographic element comprising a medium and a hologram disposed throughout the volume of the medium, wherein an optical characteristic of the element changes as a result of a variation of a physical property occurring throughout the volume of the medium, and wherein the variation arises as a result of interaction between the medium and the analyte; and detecting any change of the optical characteristic of the element; wherein (a) the medium comprises a group which is capable of reacting with the analyte, wherein the analyte or the group is capable of existing in a plurality of forms, and the detecting is conducted in the presence of a first catalyst which is capable of catalysing the conversion of a relatively less reactive form of the analyte or group to a relatively more reactive form; or (b) the fluid comprises a component, other than the analyte, which is capable of interacting with the medium, and the
- detection preferably takes place in the presence of a catalyst which catalyses the conversion of ⁇ -D-glucopyranose, ⁇ -D- glucofuranose and/or D-glucose aldehyde to ⁇ -D-glucofuranose. More preferably, detection takes place in the presence of mutarotase and/or glucose isomerase.
- Another aspect of the invention is an ophthalmic device which comprises a holographic element and a catalyst as defined above. The insert may be in the form of a contact lens or implantable device. Description of the Invention
- glucose refers to the known cyclic and linear forms of glucose.
- ophthalmic device refers to contact lenses
- the term "contact lens” as used herein refers to any hard or soft lens used on the eye or ocular vicinity for vision correction, diagnosis, sample collection, drug delivery, wound healing, cosmetic appearance or other ophthalmic application.
- the lens may be a daily-disposable, daily-wear or extended-wear lens.
- implantable ophthalmic device refers to an ophthalmic device which is used in, on or about the eye or ocular vicinity. Such devices include intraocular lenses, subconjunctival lenses, intracomeal lenses, and shunts/implants (e.g.
- a stent or glaucoma shunt that can rest in the cul de sac of an eye.
- the interaction between the medium and the analyte may be physical and/or chemical.
- the sensor may allow for the continuous detection of an analyte.
- the analyte may be able to exist in a plurality of forms.
- a catalyst may be used that catalyses the conversion of the analyte to a more reactive form.
- An example of such an analyte is glucose, which via mutarotation is able to exist in five different forms.
- the catalyst may be an enzyme such as mutarotase or glucose isomerase, allowing the rate of conversion to ⁇ -D-glucofuranose to increase.
- a medium comprising phenylboronic acid or like groups is used, the extent of reaction between glucose and the medium will be enhanced. Lactate (lactic acid) is known to interfere with the sensing of glucose. This is a particular problem in the eye, where lactate is present at relatively high concentration.
- the catalyst thus may promote the removal of lactate.
- lactate oxidase may be used. This enzyme catalyses the breakdown of lactate to (via a pyruvate intermediate) hydrogen peroxide.
- Hydrogen peroxide may react with silver and thus, if the sensor is silver-based, it is preferred that an enzyme such as catalase is present to remove any unwanted hydrogen peroxide produced.
- An alternative to lactate oxidase is lactate dehydrogenase, which converts lactic acid into pyruvate without the production of hydrogen peroxide.
- lactate dehydrogenase which converts lactic acid into pyruvate without the production of hydrogen peroxide.
- an enzyme such as glucose oxidase may be used.
- the interaction between the medium and analyte can be detected remotely, using non-ionising radiation.
- the extent of interaction is reflected in the degree of change of the physical property, which is detected as a variation in an optical characteristic, preferably a shift in wavelength of non-ionising radiation.
- the property of the holographic element which varies may be its charge density, volume, shape, density, viscosity, strength, hardness, charge, hydrophobicity, swellability, integrity, cross-link density or any other physical property. Variation of the or each physical property, in turn, causes a variation of an optical characteristic, such as polarisability, reflectance, refractance or absorbance of the holographic element.
- the hologram may be disposed on or in, part of or throughout the bulk of the volume of the support medium.
- An illuminating source of non-ionising radiation may be used to observe variation(s) in the, or each, optical characteristic of the holographic element.
- the holographic effect may be exhibited by illumination (e.g. under white light, UV or infra-red radiation), specific temperature, magnetic or pressure conditions, or particular chemical, biochemical or biological stimuli.
- the hologram may be an image of an object or a 2- or 3-dimensional effect, and may be in the form of a pattern which is only visible under magnification.
- the hologram can be generated by the diffraction of light.
- the holographic element may further comprise means for producing an interference effect when illuminated with laser light and such means can comprises a depolarising layer.
- More than one hologram may be supported on, or in, a holographic element.
- Means may be provided to detect the or each variation in radiation emanating from the or each hologram, arising as a result of a variation in the or each optical characteristic.
- the holographic elements may be dimensioned and arranged so as to sense two or more independent events/species and to affect, simultaneously, or otherwise, radiation in two or more different ways.
- Holographic elements may be provided in the form of an array.
- the holographic support medium may be obtained by the polymerisation of monomers, such as (meth)acrylamide and/or (meth)acrylate-derived comonomers.
- the monomer HEMA hydroxyethyl methacrylate
- PolyHEMA is a versatile support material since it is swellable, hydrophilic and widely biocompatible.
- Other examples of holographic support media which may be modified to include boronic acid groups are gelatin, K-carageenan, agar, agarose, polyvinyl alcohol (PVA), sol-gels (as broadly classified), hydro-gels (as broadly classified), and acrylates.
- a parameter determining the response of a holographic element is the extent of cross-linking. The number of cross-linking points due to polymerisation of monomers should not be so great that complex formation between polymer and analyte-binding groups is relatively low, since the polymer film may become too rigid. This may inhibit the swelling of the support medium.
- an insert of the invention is in the form of a contact lens.
- the lens may be manufactured using any suitable material known in the art.
- the lens material may be formed by the polymerisation of one or more monomers and optionally one or more prepolymers.
- the material may comprise a photoinitiator, visibility tinting agent, UV-blocking agent and/or a photosensitiser.
- a preferred group of lens materials is prepolymers which are water- soluble and/or meltable. It is preferred that the material comprises one or more prepolymers which are in a substantially pure form (e.g. purified by ultrafiltration).
- Preferred prepolymers include water-soluble crosslinkable poly(vinyl alcohol) prepolymers (as described in US5583163 and US6303687); a water-soluble vinyl group-terminated polyurethane, obtainable by reacting an isocyanate-capped polyurethane with an ethylenically unsaturated amine (primary or secondary amine) or an ethylenically unsaturated monohydroxy compound, wherein the isocyanate-capped polyurethane can be a copolymerisation product of at least one polyalkylene glycol, a compound containing at least 2 hydroxyl groups, and at least one compound with two or more isocyanate groups; derivatives of a polyvinyl alcohol, polyethyleneimine or polyvinylamine (see, for example, US5849841 ); a water-soluble cross-linkable polyurea prepolymer as described in US6479587; cross-linkable polyacrylamide; cross-linkable statistical copolymers of vinyl lactam,
- the lens may comprise a hydrogel material.
- hydrogel materials are polymeric materials which are capable of absorbing at least 10% by weight of water when fully hydrated.
- Hydrogel materials include polyvinyl alcohol (PVA), modified PVA (e.g. nelfilcon A), poly(hydroxyethyl methacrylate), poly(vinyl pyrrolidone), PVA with a poly(carboxylic acid) (e.g. carbopol), poly(ethylene glycol), polyacrylamide, polymethacrylamide, silicone-containing hydrogels, polyurethane, polyurea, and the like.
- the ophthalmic device may be an implantable ophthalmic device. Glucose levels in tears may be much lower than blood glucose levels.
- the device is in the form of a subconjunctive implant, intracomeal lens, stent or glaucoma shunt.
- the lens outer comprises a catalyst of the invention. In this way, it may be possible to block the interference of a component other than the analyte, which interacts with the medium.
- the method of the invention may be used to authenticate an article.
- the holographic element is a sensor
- the sensor may be applied to an article using a transferable holographic film which is, for example, provided on a hot stamping tape.
- the article may be a transaction card, banknote, passport, identification card, smart card, driving licence, share certificate, bond, cheque, cheque card, tax banderole, gift voucher, postage stamp, rail or air ticket, telephone card, lottery card, event ticket, credit or debit card, business card, or an item used in consumer, brand and product protection for the purpose of distinguishing genuine products from counterfeit products and identifying stolen products.
- the sensors may be used to provide product and pack information for intelligent packaging applications.
- Intelligent packaging refers to a system that comprises part of, or an attachment to, a container, wrapper or enclosure, to monitor, indicate or test product information or quality or environmental conditions that will affect product quality, shelf life or safety and typical applications, such as indicators showing time-temperature, freshness, moisture, alcohol, gas, physical damage and the like.
- the sensors can be applied to products with a decorative element or application such as any industrial or handicraft item including but not limited to items of jewellery, items of clothing (including footwear), fabric, furniture, toys, gifts, household items (including crockery and glassware), architecture (including glass, tile, paint, metals, bricks, ceramics, wood, plastics and other internal and external installations), art (including pictures, sculpture, pottery and light installations), stationery (including greetings cards, letterheads and promotional material) and sporting goods.
- a diagnostic device such as a test strip, chip, cartridge, swab, tube, pipette or any form of liquid sampling or testing device, and products or processes relating to human or veterinary prognostics, theranostics, diagnostics or medicines.
- the sensors may be used in a contact lens, sub-conjuctival implant, sub-dermal implant, test strip, chip, cartridge, swab, tube, breathalyser, catheter, any form or blood, urine or body fluid sampling or analysis device.
- the sensors may also be used in a product or process relating to petrochemical and chemical analysis and testing, for example in a testing device such as a test strip, chip, cartridge, swab, tube, pipette or any form of liquid sampling or analysis device.
- the present invention also extends to a product suitable for use in the method of the invention comprising a holographic element where the product is capable of generating data from the holographic element and to a system which uses the data for data storage, control, transmission, reporting and/or modelling.
- a holographic sensor comprising a polymeric support medium containing 12 mol% 3-acrylamidophenylboronic acid (the synthesis of which is described in WO2004/081624).
- the ⁇ -and ⁇ -D-glucopyranose forms of glucose were obtained from Sigma in solid form. Mutarotase was purchased from Biozyme and originated from porcine kidney.
- Glucose isomerase was obtained from Hampton Research and originated from Streptomyces rubiginosus. Lactate oxidase was purchased from Sigma and originated from Pediococcus sp. Detection took place in PBS, pH 7.4 at 30°C.
- Example 1 Freshly-dissolved ⁇ -glucopyranose was detected using a holographic sensor and the rate of binding recorded. Also, a solution of ⁇ -glucopyranose was left overnight to equilibrate, and the rate of binding then determined. The experiment was repeated using ⁇ -glucopyranose. The rate of reaction was calculated by determining the time taken for the holographic sensor to reach 50% of its final equilibrium peak diffraction wavelength (i.e.
- Example 2 A 2 mM glucose solution was made up and left overnight to equilibrate. A holographic sensor was then used to detect glucose in the presence of varying amounts of mutarotase. The initial rate of response, i.e. the initial increase in peak diffraction wavelength upon addition of the glucose solution, was determined. The results are shown in Figure 2 and indicate that, at relatively lower concentrations of mutarotase, the initial rate of binding is faster than when mutarotase is absent. The optimum amount of mutarotase was found to be 0.25 mg/ml, which increased the rate of reaction by 54% relative to the control. Example 3 The effect of glucose isomerase on the binding of glucose to a holographic sensor was determined.
- Dialysis of glucose isomerase was performed to remove the buffer that it was suspended in.
- the holographic sensor allowed to equilibrate with 1 mM MgS0 4 , Mg 2+ being a co-factor for glucose isomerase.
- a 0.5mM glucose solution was then added to the sensor in the presence of varying amounts of glucose isomerase. Results are shown in Figure 3. It can be seen that the addition of glucose isomerase enhances the sensitivity of the sensor. It is also noticeable that, the greater the quantity of glucose isomerase added, the longer the system takes to equilibrate. The initial rates of reaction are also much faster than that of the control.
- Example 4 A holographic sensor was placed in a cuvette with PBS, and 12.5 units of lactate oxidase added.
Landscapes
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plasma & Fusion (AREA)
- Engineering & Computer Science (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Diffracting Gratings Or Hologram Optical Elements (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002569540A CA2569540A1 (en) | 2004-06-07 | 2005-06-06 | Method of detecting an analyte using a holographic sensor |
BRPI0511859-0A BRPI0511859A (en) | 2004-06-07 | 2005-06-06 | method for detecting analyte using a holographic sensor |
EA200602186A EA011267B1 (en) | 2004-06-07 | 2005-06-06 | Method of detecting an analyte using a holographic sensor |
EP05747332A EP1754043A1 (en) | 2004-06-07 | 2005-06-06 | Method of detecting an analyte using a holographic sensor |
CN2005800228657A CN1997884B (en) | 2004-06-07 | 2005-06-06 | Method of detecting an analyte using a holographic sensor |
AU2005252845A AU2005252845B2 (en) | 2004-06-07 | 2005-06-06 | Method of detecting an analyte using a holographic sensor |
JP2007526535A JP4782126B2 (en) | 2004-06-07 | 2005-06-06 | Detecting specimen using holographic sensor |
US11/597,983 US20080020478A1 (en) | 2004-06-07 | 2005-06-06 | Method of Detecting an Analyte Using a Holographic Sensor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0412654.6 | 2004-06-07 | ||
GBGB0412654.6A GB0412654D0 (en) | 2004-06-07 | 2004-06-07 | Method of detection |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005121753A1 true WO2005121753A1 (en) | 2005-12-22 |
Family
ID=32696777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2005/002222 WO2005121753A1 (en) | 2004-06-07 | 2005-06-06 | Method of detecting an analyte using a holographic sensor |
Country Status (11)
Country | Link |
---|---|
US (1) | US20080020478A1 (en) |
EP (1) | EP1754043A1 (en) |
JP (1) | JP4782126B2 (en) |
KR (1) | KR20070054601A (en) |
CN (1) | CN1997884B (en) |
AU (1) | AU2005252845B2 (en) |
BR (1) | BRPI0511859A (en) |
CA (1) | CA2569540A1 (en) |
EA (1) | EA011267B1 (en) |
GB (1) | GB0412654D0 (en) |
WO (1) | WO2005121753A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007010241A2 (en) * | 2005-07-18 | 2007-01-25 | Smart Holograms Limited | Holographic sensors and their uses |
WO2007039717A1 (en) * | 2005-10-03 | 2007-04-12 | Smart Holograms Limited | Use of holographic sensors |
WO2007054689A1 (en) * | 2005-11-08 | 2007-05-18 | Smart Holograms Limited | Novel boronate complex and its use in a glucose sensor |
WO2007083111A1 (en) * | 2006-01-18 | 2007-07-26 | Smart Holograms Limited | Method of making holograms having at least two replay colours |
JP2008253455A (en) * | 2007-04-03 | 2008-10-23 | Shimadzu Corp | Drinking detector |
US9730638B2 (en) | 2013-03-13 | 2017-08-15 | Glaukos Corporation | Intraocular physiological sensor |
US11363951B2 (en) | 2011-09-13 | 2022-06-21 | Glaukos Corporation | Intraocular physiological sensor |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090014340A1 (en) * | 2007-06-15 | 2009-01-15 | Williams John R | Devices, systems, and methods for measuring glucose |
US8181531B2 (en) * | 2008-06-27 | 2012-05-22 | Edwin Carlen | Accessible stress-based electrostatic monitoring of chemical reactions and binding |
US8232028B2 (en) * | 2008-07-24 | 2012-07-31 | Inphase Technologies, Inc. | Holographic storage medium and method for gated diffusion of photoactive monomer |
US9011670B2 (en) * | 2008-08-14 | 2015-04-21 | The Charles Stark Draper Laboratory, Inc. | Three-dimensional metal ion sensor arrays on printed circuit boards |
KR101211098B1 (en) | 2011-04-25 | 2012-12-11 | (주)엔써즈 | System and method for providing advertisement related informatiion included in broadcasting to client terminal through network |
KR101310943B1 (en) | 2011-09-26 | 2013-09-23 | (주)엔써즈 | System and method for providing contents-related information associated with broadcasting contents |
KR101404596B1 (en) | 2012-05-03 | 2014-06-11 | (주)엔써즈 | System and method for providing video service based on image data |
KR101315970B1 (en) | 2012-05-23 | 2013-10-08 | (주)엔써즈 | Apparatus and method for recognizing content using audio signal |
US8886635B2 (en) | 2012-05-23 | 2014-11-11 | Enswers Co., Ltd. | Apparatus and method for recognizing content using audio signal |
KR101369475B1 (en) | 2013-01-23 | 2014-03-06 | (주)엔써즈 | System and method for surveying broadcasting audience rating |
KR101456926B1 (en) | 2013-06-14 | 2014-10-31 | (주)엔써즈 | System and method for detecting advertisement based on fingerprint |
US9095312B2 (en) | 2013-10-17 | 2015-08-04 | Google Inc. | Method and system for measuring pyruvate |
JP6766641B2 (en) * | 2016-12-27 | 2020-10-14 | コニカミノルタ株式会社 | Image processing device, its control method and program |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5342672A (en) * | 1992-09-14 | 1994-08-30 | Weber Marking Systems, Inc. | Holographic thermal transfer ribbon |
WO1995026499A1 (en) * | 1994-03-28 | 1995-10-05 | British Technology Group Limited | Hologram used as a sensor |
WO1999034244A1 (en) * | 1997-12-29 | 1999-07-08 | Novartis Ag | Programmable corrective lens |
US20030027240A1 (en) * | 1996-11-06 | 2003-02-06 | University Of Pittsburgh | Intelligent polymerized crystalline colloidal array carbohydrate sensors |
US20030103868A1 (en) * | 2000-01-07 | 2003-06-05 | Millington Roger Bradley | Sensor with holographic multiplexed image display |
US6579673B2 (en) * | 1998-12-17 | 2003-06-17 | Kimberly-Clark Worldwide, Inc. | Patterned deposition of antibody binding protein for optical diffraction-based biosensors |
US20030187338A1 (en) * | 1998-04-30 | 2003-10-02 | Therasense, Inc. | Analyte monitoring device and methods of use |
WO2003087899A1 (en) * | 2002-04-05 | 2003-10-23 | Smart Holograms Limited | Method of detecting an analyte in a fluid |
WO2004081624A1 (en) * | 2003-03-11 | 2004-09-23 | Smart Holograms Limited | Holographic sensor |
WO2005031442A1 (en) * | 2003-09-25 | 2005-04-07 | Smart Holograms Limited | Ophthalmic device comprising a holographic sensor |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US534672A (en) * | 1895-02-26 | Trousers-stretcher | ||
DE3824258C2 (en) * | 1987-07-23 | 1999-04-29 | Bst Bio Sensor Tech Gmbh | Modified enzyme membrane for enzyme electrodes with high selectivity and process for their application |
JPH07165781A (en) * | 1993-12-07 | 1995-06-27 | Asai Gerumaniumu Kenkyusho:Kk | Method for isomerizing glucose and isomerizing agent or promoter therefor |
US5426570A (en) * | 1994-03-31 | 1995-06-20 | Davis; Mckay H. | Battery system for sustained bicycle pathway illumination, and methods |
US5800624A (en) * | 1996-10-22 | 1998-09-01 | University Of Notre Dame | Membrane process for separating carbohydrates |
US5898004A (en) * | 1996-11-06 | 1999-04-27 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Polymerized crystalline colloidal array sensors |
US6399295B1 (en) * | 1999-12-17 | 2002-06-04 | Kimberly-Clark Worldwide, Inc. | Use of wicking agent to eliminate wash steps for optical diffraction-based biosensors |
WO2003001499A1 (en) * | 2001-06-26 | 2003-01-03 | Seiko Epson Corporation | Image display system, projector, image processing method, and information recording medium |
-
2004
- 2004-06-07 GB GBGB0412654.6A patent/GB0412654D0/en not_active Ceased
-
2005
- 2005-06-06 BR BRPI0511859-0A patent/BRPI0511859A/en not_active IP Right Cessation
- 2005-06-06 JP JP2007526535A patent/JP4782126B2/en not_active Expired - Fee Related
- 2005-06-06 WO PCT/GB2005/002222 patent/WO2005121753A1/en active Application Filing
- 2005-06-06 CN CN2005800228657A patent/CN1997884B/en not_active Expired - Fee Related
- 2005-06-06 EA EA200602186A patent/EA011267B1/en not_active IP Right Cessation
- 2005-06-06 AU AU2005252845A patent/AU2005252845B2/en not_active Ceased
- 2005-06-06 CA CA002569540A patent/CA2569540A1/en not_active Abandoned
- 2005-06-06 EP EP05747332A patent/EP1754043A1/en not_active Withdrawn
- 2005-06-06 KR KR1020067025709A patent/KR20070054601A/en not_active Application Discontinuation
- 2005-06-06 US US11/597,983 patent/US20080020478A1/en not_active Abandoned
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5342672A (en) * | 1992-09-14 | 1994-08-30 | Weber Marking Systems, Inc. | Holographic thermal transfer ribbon |
WO1995026499A1 (en) * | 1994-03-28 | 1995-10-05 | British Technology Group Limited | Hologram used as a sensor |
US20030027240A1 (en) * | 1996-11-06 | 2003-02-06 | University Of Pittsburgh | Intelligent polymerized crystalline colloidal array carbohydrate sensors |
WO1999034244A1 (en) * | 1997-12-29 | 1999-07-08 | Novartis Ag | Programmable corrective lens |
US20030187338A1 (en) * | 1998-04-30 | 2003-10-02 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6579673B2 (en) * | 1998-12-17 | 2003-06-17 | Kimberly-Clark Worldwide, Inc. | Patterned deposition of antibody binding protein for optical diffraction-based biosensors |
US20030103868A1 (en) * | 2000-01-07 | 2003-06-05 | Millington Roger Bradley | Sensor with holographic multiplexed image display |
WO2003087899A1 (en) * | 2002-04-05 | 2003-10-23 | Smart Holograms Limited | Method of detecting an analyte in a fluid |
WO2004081624A1 (en) * | 2003-03-11 | 2004-09-23 | Smart Holograms Limited | Holographic sensor |
WO2005031442A1 (en) * | 2003-09-25 | 2005-04-07 | Smart Holograms Limited | Ophthalmic device comprising a holographic sensor |
Non-Patent Citations (2)
Title |
---|
ANONYMOUS: "Multilayer analytical elements for use in the automated clinical analysis of glucose using an enzyme preparation containing both glucose oxidase and mutarotase", RESEARCH DISCLOSURE, KENNETH MASON PUBLICATIONS, WESTBOURNE, GB, vol. 139, no. 53, November 1975 (1975-11-01), XP007103572, ISSN: 0374-4353 * |
SHOJI E ET AL: "POTENTIOMETRIC SACCHARIDE DETECTION BASED ON THE PKA CHANGES OF POLY(ANILINE BORONIC ACID)", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 124, no. 42, 2002, pages 12486 - 12493, XP001152436, ISSN: 0002-7863 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007010241A2 (en) * | 2005-07-18 | 2007-01-25 | Smart Holograms Limited | Holographic sensors and their uses |
WO2007010241A3 (en) * | 2005-07-18 | 2007-03-08 | Smart Holograms Ltd | Holographic sensors and their uses |
WO2007039717A1 (en) * | 2005-10-03 | 2007-04-12 | Smart Holograms Limited | Use of holographic sensors |
WO2007054689A1 (en) * | 2005-11-08 | 2007-05-18 | Smart Holograms Limited | Novel boronate complex and its use in a glucose sensor |
US8334140B2 (en) | 2005-11-08 | 2012-12-18 | Smart Holograms Limited | Boronate complex and its use in a glucose sensor |
WO2007083111A1 (en) * | 2006-01-18 | 2007-07-26 | Smart Holograms Limited | Method of making holograms having at least two replay colours |
JP2008253455A (en) * | 2007-04-03 | 2008-10-23 | Shimadzu Corp | Drinking detector |
US11363951B2 (en) | 2011-09-13 | 2022-06-21 | Glaukos Corporation | Intraocular physiological sensor |
US9730638B2 (en) | 2013-03-13 | 2017-08-15 | Glaukos Corporation | Intraocular physiological sensor |
US10849558B2 (en) | 2013-03-13 | 2020-12-01 | Glaukos Corporation | Intraocular physiological sensor |
Also Published As
Publication number | Publication date |
---|---|
JP2008501970A (en) | 2008-01-24 |
EP1754043A1 (en) | 2007-02-21 |
EA200602186A1 (en) | 2007-06-29 |
KR20070054601A (en) | 2007-05-29 |
AU2005252845B2 (en) | 2009-04-23 |
CA2569540A1 (en) | 2005-12-22 |
CN1997884B (en) | 2012-05-09 |
JP4782126B2 (en) | 2011-09-28 |
BRPI0511859A (en) | 2008-01-15 |
EA011267B1 (en) | 2009-02-27 |
CN1997884A (en) | 2007-07-11 |
AU2005252845A1 (en) | 2005-12-22 |
US20080020478A1 (en) | 2008-01-24 |
GB0412654D0 (en) | 2004-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005252845B2 (en) | Method of detecting an analyte using a holographic sensor | |
US8241574B2 (en) | Ophthalmic device comprising a holographic sensor | |
AU2003229893B8 (en) | Method of detecting an analyte in a fluid | |
US8334140B2 (en) | Boronate complex and its use in a glucose sensor | |
US20070171491A1 (en) | Holographic or diffraction devices | |
AU2004276949B2 (en) | Ophthalmic device comprising a holographic sensor | |
JP4911641B2 (en) | Holographic sensor with polymer matrix | |
AU2005263970B2 (en) | Holographic sensor having heterogeneous properties | |
US7923678B2 (en) | Sensing method including interrogation of a holographic sensor | |
US20100143827A1 (en) | Methods of Making Holographic Devices | |
WO2006120426A1 (en) | Sensor | |
WO2006120430A1 (en) | Method of recording a hologram | |
AU2006271429A1 (en) | Interrogation of a light-sensitive sensor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005747332 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2569540 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067025709 Country of ref document: KR Ref document number: 2007526535 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005252845 Country of ref document: AU |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580022865.7 Country of ref document: CN Ref document number: 163/DELNP/2007 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200602186 Country of ref document: EA |
|
ENP | Entry into the national phase |
Ref document number: 2005252845 Country of ref document: AU Date of ref document: 20050606 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005252845 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005747332 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11597983 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0511859 Country of ref document: BR |
|
WWP | Wipo information: published in national office |
Ref document number: 11597983 Country of ref document: US |